Imbalances in neurotrophin signaling pathways, as well as alterations in brain cholesterol metabolism, are strongly associated with neurologic and neurodegenerative diseases, such as Rett syndrome, HD, Alzheimer’s disease (AD), and Parkinson’s disease (PD) [2,38,39]. This evidence concerns the gene BDNF and Huntington disease.